Symbols

Why Did Scinai Immunotherapeutics Ltd. (SCNI) Soar 12.92%?

Generated by AI AgentAinvest Pre-Market Radar

Thursday, Aug 21, 2025 8:13 am ET1min read

SCNI--

Aime Summary

- Scinai Immunotherapeutics (SCNI) surged 12.92% in pre-market trading on August 21, 2025.

- The stock showed 52-week volatility ($1.40-$6.18) and a 0.65% rise to $1.54 on August 19.

- High short interest (70.43% of float) signals bearish sentiment and potential price swings.

- A 5.8% gain to $1.64 on August 20 reflected positive investor sentiment and $1.4M market cap.

On August 21, 2025, ScinaiSCNI-- Immunotherapeutics Ltd. American Depositary Shares (SCNI) surged by 12.92% in pre-market trading, marking a significant rise in its stock price.

Scinai Immunotherapeutics Ltd. has seen notable fluctuations in its stock price, with a 52-week high of $6.18 and a 52-week low of $1.40. The company's stock price on August 19, 2025, was $1.54, reflecting a 0.65% increase from the previous trading day.

Scinai Immunotherapeutics has a substantial short interest, with 275,400 shares shorted, representing 70.43% of the float. This high short interest indicates significant bearish sentiment among investors, which could contribute to volatility in the stock price.

On August 20, 2025, Scinai Immunotherapeutics' stock price moved upwards by 5.8% to $1.64, driven by positive market sentiment and investor interest. The market value of their outstanding shares is at $1.4 million, reflecting the company's current market capitalization.

Ainvest Pre-Market Radar

Get the scoop on pre-market movers and shakers in the US stock market.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue